- Home
- KLRS vs LGO Comparison
KLRS vs LGO Comparison
Compare KLRS & LGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- LGO
- Stock Information
- Founded
- KLRS 2019
- LGO 1988
- Country
- KLRS United States
- LGO Canada
- Employees
- KLRS N/A
- LGO N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- LGO
- Sector
- KLRS Health Care
- LGO
- Exchange
- KLRS Nasdaq
- LGO Nasdaq
- Market Cap
- KLRS 129.0M
- LGO 104.5M
- IPO Year
- KLRS N/A
- LGO 2007
- Fundamental
- Price
- KLRS $3.89
- LGO $1.47
- Analyst Decision
- KLRS Buy
- LGO Strong Buy
- Analyst Count
- KLRS 1
- LGO 1
- Target Price
- KLRS N/A
- LGO $3.90
- AVG Volume (30 Days)
- KLRS 62.9K
- LGO 66.2K
- Earning Date
- KLRS 05-19-2025
- LGO 05-14-2025
- Dividend Yield
- KLRS N/A
- LGO N/A
- EPS Growth
- KLRS N/A
- LGO N/A
- EPS
- KLRS N/A
- LGO N/A
- Revenue
- KLRS N/A
- LGO $124,920,000.00
- Revenue This Year
- KLRS N/A
- LGO $23.62
- Revenue Next Year
- KLRS N/A
- LGO $24.21
- P/E Ratio
- KLRS N/A
- LGO N/A
- Revenue Growth
- KLRS N/A
- LGO N/A
- 52 Week Low
- KLRS $4.19
- LGO $1.12
- 52 Week High
- KLRS $24.15
- LGO $2.84
- Technical
- Relative Strength Index (RSI)
- KLRS N/A
- LGO 43.12
- Support Level
- KLRS N/A
- LGO $1.45
- Resistance Level
- KLRS N/A
- LGO $1.48
- Average True Range (ATR)
- KLRS 0.00
- LGO 0.08
- MACD
- KLRS 0.00
- LGO -0.01
- Stochastic Oscillator
- KLRS 0.00
- LGO 23.47
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics. Kalaris is developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body native, highest affinity VEGF receptor 1.
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.